369
Views
14
CrossRef citations to date
0
Altmetric
Original Research

Minimal Clinically Important Differences for Patient-Reported Outcome Measures of Cough and Sputum in Patients with COPD

ORCID Icon, ORCID Icon, ORCID Icon, , ORCID Icon & ORCID Icon
Pages 201-212 | Published online: 29 Jan 2020

References

  • Forum of International Respiratory Societies. The Global Impact of Respiratory Disease. 2nd ed. Sheffield: European Respiratory Society; 2017.
  • López‐CamposJL, TanW, SorianoJB. Global burden of COPD. Respirology. 2016;21(1):14–23. doi:10.1111/resp.1266026494423
  • Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease (2019 Report). 2019.
  • KesslerR, PartridgeMR, MiravitllesM, et al. Symptom variability in patients with severe COPD – a pan-European cross-sectional study. Eur Respir J. 2011;37(2):264–272. doi:10.1183/09031936.0005111021115606
  • MiravitllesM, WorthH, CataluñaJJS, et al. Observational study to characterise 24-hour COPD symptoms and their relationship with patient-reported outcomes: results from the ASSESS study. Respir Res. 2014;15(1):122. doi:10.1186/s12931-014-0122-125331383
  • CrooksMG, BrownT, MoriceAH. Is cough important in acute exacerbations of COPD? Respir Physiol Neurobiol. 2018;257:30–35. doi:10.1016/j.resp.2018.02.00529438811
  • MiravitllesM, RiberaA. Understanding the impact of symptoms on the burden of COPD. Respir Res. 2017;18(1):67. doi:10.1186/s12931-017-0548-328431503
  • SatiaI, BadriH, LahousseL, UsmaniOS, SpanevelloA. Airways diseases: asthma, COPD and chronic cough highlights from the European Respiratory Society Annual Congress 2018. J Thorac Dis. 2018;10(Suppl 25):S2992. doi:10.21037/jtd.2018.08.2330310687
  • CrooksMG, HaymanY, InnesA, WilliamsonJ, WrightCE, MoriceAH. Objective measurement of cough frequency during COPD exacerbation convalescence. Lung. 2016;194(1):117–120. doi:10.1007/s00408-015-9782-y26280405
  • SmithJ, WoodcockA. Cough and its importance in COPD. Int J Chron Obstruct Pulmon Dis. 2006;1(3):305.18046867
  • van BuulAR, KasteleynMJ, ChavannesNH, TaubeC. Morning symptoms in COPD: a treatable yet often overlooked factor. Expert Rev Respir Med. 2017;11(4):311–322. doi:10.1080/17476348.2017.130589428282500
  • CalverleyPM. Cough in chronic obstructive pulmonary disease: is it important and what are the effects of treatment? Cough. 2013;9(1):17. doi:10.1186/1745-9974-9-1723799979
  • SpruitMA, SinghSJ, GarveyC, et al. An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation. Am J Respir Crit Care Med. 2013;188(8):e13–e64. doi:10.1164/rccm.201309-1634ST24127811
  • McCarthyB, CaseyD, DevaneD, MurphyK, MurphyE, LacasseY. Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2015;23(2):CD003793.
  • JohnstonBC, EbrahimS, Carrasco-LabraA, et al. Minimally important difference estimates and methods: a protocol. BMJ Open. 2015;5(10):e007953. doi:10.1136/bmjopen-2015-007953
  • GuyattGH, OsobaD, WuAW, WyrwichKW, NormanGR. Methods to explain the clinical significance of health status measures. Mayo Clin Proc. 2002;77(4):371–383. doi:10.4065/77.4.37111936935
  • JaeschkeR, SingerJ, GuyattGH. Measurement of health status: ascertaining the minimal clinically important difference. Control Clin Trials. 1989;10(4):407–415. doi:10.1016/0197-2456(89)90005-62691207
  • JonesP. Interpreting thresholds for a clinically significant change in health status in asthma and COPD. Eur Respir J. 2002;19(3):398–404. doi:10.1183/09031936.02.0006370211936514
  • AngstF, AeschlimannA, AngstJ. The minimal clinically important difference raised the significance of outcome effects above the statistical level, with methodological implications for future studies. J Clin Epidemiol. 2017;82:128–136. doi:10.1016/j.jclinepi.2016.11.01627986610
  • WrightA, HannonJ, HegedusEJ, KavchakAE. Clinimetrics corner: a closer look at the minimal clinically important difference (MCID). J Man Manip Ther. 2012;20(3):160–166. doi:10.1179/2042618612Y.000000000123904756
  • AlmaH, de JongC, TsiligianniI, SandermanR, KocksJ, van der MolenT. Clinically relevant differences in COPD health status: systematic review and triangulation. Eur Respir J. 2018;52(3):1800412. doi:10.1183/13993003.00412-201830139774
  • BirringS, PrudonB, CarrA, SinghS, MorganM, PavordI. Development of a symptom specific health status measure for patients with chronic cough: Leicester Cough Questionnaire (LCQ). Thorax. 2003;58(4):339–343. doi:10.1136/thorax.58.4.33912668799
  • CrawfordB, MonzB, HohlfeldJ, et al. Development and validation of a cough and sputum assessment questionnaire. Respir Med. 2008;102(11):1545–1555. doi:10.1016/j.rmed.2008.06.00918662868
  • CharlsonM, SzatrowskiTP, PetersonJ, GoldJ. Validation of a combined comorbidity index. J Clin Epidemiol. 1994;47(11):1245–1251. doi:10.1016/0895-4356(94)90129-57722560
  • BestallJ, PaulE, GarrodR, GarnhamR, JonesP, WedzichaJ. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax. 1999;54(7):581–586. doi:10.1136/thx.54.7.58110377201
  • JonesPW, HardingG, BerryP, WiklundI, ChenWH, Kline LeidyN. Development and first validation of the COPD assessment test. Eur Respir J. 2009;34(3):648–654. doi:10.1183/09031936.0010250919720809
  • JonesPW, QuirkFH, BaveystockCM, LittlejohnsP. A self-complete measure of health status for chronic airflow limitation. Am Rev Respir Dis. 1992;145(6):1321–1327. doi:10.1164/ajrccm/145.6.13211595997
  • BerkhofFF, BoomLN, Ten HertogNE, UilSM, KerstjensHA, van den BergJW. The validity and precision of the Leicester Cough Questionnaire in COPD patients with chronic cough. Health Qual Life Outcomes. 2012;10(1):4. doi:10.1186/1477-7525-10-422230731
  • FaruqiS, ThompsonR, WrightC, SheedyW, MoriceAH. Quantifying chronic cough: objective versus subjective measurements. Respirology. 2011;16(2):314–320. doi:10.1111/res.2011.16.issue-221054670
  • KelsallA, DecalmerS, WebsterD, et al. How to quantify coughing: correlations with quality of life in chronic cough. Eur Respir J. 2008;32(1):175–179. doi:10.1183/09031936.0010130718287128
  • DesleeG, BurgelP-R, EscamillaR, et al. Impact of current cough on health-related quality of life in patients with COPD. Int J Chron Obstruct Pulmon Dis. 2016;11:2091. doi:10.2147/COPD27695305
  • MonzBU, SachsP, McDonaldJ, CrawfordB, NivensMC, TetzlaffK. Responsiveness of the cough and sputum assessment questionnaire in exacerbations of COPD and chronic bronchitis. Respir Med. 2010;104(4):534–541. doi:10.1016/j.rmed.2009.10.02619917525
  • KamperSJ, MaherCG, MackayG. Global rating of change scales: a review of strengths and weaknesses and considerations for design. J Man Manip Ther. 2009;17(3):163–170. doi:10.1179/jmt.2009.17.3.16320046623
  • MarquesA, JácomeC, RebeloP, et al. Improving access to community-based pulmonary rehabilitation: 3R protocol for real-world settings with cost-benefit analysis. BMC Public Health. 2019;19:676. doi:10.1186/s12889-019-7045-131151409
  • AlisonJA, McKeoughZJ, JohnstonK, et al. Australian and New Zealand pulmonary rehabilitation guidelines. Respirology. 2017;22(4):800–819. doi:10.1111/resp.2017.22.issue-428339144
  • McHorneyCA, TarlovAR. Individual-patient monitoring in clinical practice: are available health status surveys adequate? Qual Life Res. 1995;4(4):293–307. doi:10.1007/BF15938827550178
  • AggarwalR, RanganathanP. Common pitfalls in statistical analysis: the use of correlation techniques. Perspect Clin Res. 2016;7(4):187. doi:10.4103/2229-3485.19204627843795
  • RevickiD, HaysRD, CellaD, SloanJ. Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes. J Clin Epidemiol. 2008;61(2):102–109. doi:10.1016/j.jclinepi.2007.03.01218177782
  • DoiSA, ThalibL. A quality-effects model for meta-analysis. Epidemiology. 2008;19(1):94–100. doi:10.1097/EDE.0b013e31815c24e718090860
  • OliveiraA, MachadoA, MarquesA. Minimal important and detectable differences of respiratory measures in outpatients with AECOPD. COPD. 2018;1–10.
  • JonesPW. St. George’s respiratory questionnaire: MCID. COPD. 2005;2(1):75–79. doi:10.1081/COPD-20005051317136966
  • KonSS, CanavanJL, JonesSE, et al. Minimum clinically important difference for the COPD assessment test: a prospective analysis. Lancet Respir Med. 2014;2(3):195–203. doi:10.1016/S2213-2600(14)70001-324621681
  • TerweeCB, BotSD, de BoerMR, et al. Quality criteria were proposed for measurement properties of health status questionnaires. J Clin Epidemiol. 2007;60(1):34–42. doi:10.1016/j.jclinepi.2006.03.01217161752
  • CarterJV, PanJ, RaiSN, GalandiukS. ROC-ing along: evaluation and interpretation of receiver operating characteristic curves. Surgery. 2016;159(6):1638–1645. doi:10.1016/j.surg.2015.12.02926962006
  • MandrekarJN. Receiver operating characteristic curve in diagnostic test assessment. J Thorac Oncol. 2010;5(9):1315–1316. doi:10.1097/JTO.0b013e3181ec173d20736804
  • AlmaH, De JongC, JelusicD, et al. Health status instruments for patients with COPD in pulmonary rehabilitation: defining a minimal clinically important difference. NPJ Prim Care Respir Med. 2016;26:16041. doi:10.1038/npjpcrm.2016.4127597571
  • CopayAG, SubachBR, GlassmanSD, PollyDW, SchulerTC. Understanding the minimum clinically important difference: a review of concepts and methods. Spine J. 2007;7(5):541–546. doi:10.1016/j.spinee.2007.01.00817448732
  • CohenJ. A power primer. Psychol Bull. 1992;112(1):155. doi:10.1037/0033-2909.112.1.15519565683
  • KangH. The prevention and handling of the missing data. Korean J Anesthesiol. 2013;64(5):402. doi:10.4097/kjae.2013.64.5.40223741561
  • WellsBJ, ChaginKM, NowackiAS, KattanMW. Strategies for handling missing data in electronic health record derived data. EGEMS. 2013;1:3. doi:10.13063/2327-9214.1035
  • RajA, PavordD, BirringS. Clinical cough IV: what is the minimal important difference for the Leicester Cough Questionnaire? Pharmacol Ther Cough. 2009;311–320.
  • BrokkaarL, UilSM, Van Den BergJWK. Minimal Clinically Important Difference (MCID) of the Dutch version of the Leicester Cough Questionnaire and baseline predictors of reaching the MCID after six months. Chest. 2007;132(4):468B. doi:10.1378/chest.132.4_MeetingAbstracts.468b
  • LeeKK, MatosS, EvansDH, WhiteP, PavordID, BirringSS. A longitudinal assessment of acute cough. Am J Respir Crit Care Med. 2013;187(9):991–997. doi:10.1164/rccm.201209-1686OC23471466
  • YousafN, LeeKK, JayaramanB, PavordID, BirringSS. The assessment of quality of life in acute cough with the Leicester Cough Questionnaire (LCQ-acute). Cough. 2011;7(1):4. doi:10.1186/1745-9974-7-421767404
  • Houchen-WolloffL, EvansRA. Unravelling the mystery of the ‘minimum important difference’ using practical outcome measures in chronic respiratory disease. Chron Respir Dis. 2019;16:1479973118816491. doi:10.1177/147997311881649130789024
  • ArikanH, SavciS, Calik-KutukcuE, et al. The relationship between cough-specific quality of life and abdominal muscle endurance, fatigue, and depression in patients with COPD. Int J Chron Obstruct Pulmon Dis. 2015;10:1829.26379433
  • PolleyL, YamanN, HeaneyL, et al. Impact of cough across different chronic respiratory diseases: comparison of two cough-specific health-related quality of life questionnaires. Chest. 2008;134(2):295–302. doi:10.1378/chest.07-014118071022
  • ReychlerG, SchinckusM, FremaultA, LiistroG, PietersT. Validation of the French version of the Leicester Cough Questionnaire in chronic obstructive pulmonary disease. Chron Respir Dis. 2015;12(4):313–319. doi:10.1177/147997231560261826346891
  • KooH-K, ParkS-W, ParkJ-W, et al. Chronic cough as a novel phenotype of chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2018;13:1793. doi:10.2147/COPD29881269
  • JonesPW, BrusselleG, Dal NegroRW, et al. Patient-centred assessment of COPD in primary care: experience from a cross-sectional study of health-related quality of life in Europe. Prim Care Respir J. 2012;21(3):329. doi:10.4104/pcrj.2012.0006522885563
  • LeeH, JhunBW, ChoJ, et al. Different impacts of respiratory symptoms and comorbidities on COPD-specific health-related quality of life by COPD severity. Int J Chron Obstruct Pulmon Dis. 2017;12:3301. doi:10.2147/COPD29180860
  • MonteagudoM, Rodríguez-BlancoT, LlagosteraM, et al. Factors associated with changes in quality of life of COPD patients: a prospective study in primary care. Respir Med. 2013;107(10):1589–1597. doi:10.1016/j.rmed.2013.05.00923786889
  • MiravitllesM. Cough and sputum production as risk factors for poor outcomes in patients with COPD. Respir Med. 2011;105(8):1118–1128. doi:10.1016/j.rmed.2011.02.00321353517
  • StephensonJJ, CaiQ, MocarskiM, TanH, DoshiJA, SullivanSD. Impact and factors associated with nighttime and early morning symptoms among patients with chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2015;10:577. doi:10.2147/COPD25844033
  • MiravitllesM, FerrerJ, BaróE, LleonartM, GaleraJ. Differences between physician and patient in the perception of symptoms and their severity in COPD. Respir Med. 2013;107(12):1977–1985. doi:10.1016/j.rmed.2013.06.01923890959
  • OliveiraA, MunháJ, BugalhoA, GuimarãesM, ReisG, MarquesA. Identification and assessment of COPD exacerbations. Pulmonology. 2018;24(1):42–47. doi:10.1016/j.rppnen.2017.10.006
  • OliveiraA, AfreixoV, MarquesA. Enhancing our understanding of the time course of acute exacerbations of COPD managed on an outpatient basis. Int J Chron Obstruct Pulmon Dis. 2018;13:3759. doi:10.2147/COPD30538438
  • BeauchampMK, HarrisonSL, GoldsteinRS, BrooksD. Interpretability of change scores in measures of balance in people with COPD. Chest. 2016;149(3):696–703. doi:10.1378/chest.15-071726203790
  • HansonLC, TaylorNF, McBurneyH. Interpreting meaningful change in the distance walked in the 10-metre ISWT in cardiac rehabilitation. Heart Lung Circ. 2018.